Spectrum Brands (SPB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
5 Feb, 2026Executive summary
Q1 FY26 net sales declined 3.3% year-over-year to $677.0 million, but net income from continuing operations rose 19.5% to $29.4 million, driven by a one-time tax benefit and lower share count.
Adjusted EBITDA was $62.6 million, down 19.5% year-over-year, with margin declining to 9.2% from 11.1%.
Global Pet Care returned to growth, with net sales up 8.3% (organic +5.8%), while Home & Garden and Home & Personal Care saw declines.
Nearly $60 million in adjusted free cash flow was generated, and significant capital was returned to shareholders through buybacks, including a new $300 million repurchase program.
Strategic priorities remain: maintaining a strong balance sheet, operational excellence, investing in people, and transformation through innovation, M&A, and ERP initiatives.
Financial highlights
Q1 net sales were $677.0 million, down 3.3% year-over-year; organic net sales declined 6.0%.
Gross profit fell to $241.6 million (35.7% margin), down 6.3% year-over-year.
Operating income was $27.1 million, down from $44.7 million in the prior year.
Adjusted EBITDA was $62.6 million, down from $77.8 million; adjusted diluted EPS rose to $1.40, driven by tax benefit and share reduction.
Cash flow from operating activities improved to $67.7 million; adjusted free cash flow was $59.7 million.
Outlook and guidance
Fiscal 2026 guidance reiterated: net sales expected to be flat to up low single digits, with low single digit adjusted EBITDA growth.
Adjusted free cash flow conversion targeted at approximately 50% of adjusted EBITDA.
Growth anticipated in Global Pet Care and Home & Garden, offset by a decline in Home & Personal Care.
Q2 expected to remain challenging, with Home & Garden growth weighted to the second half.
Long-term net leverage ratio targeted at 2.0–2.5x.
Latest events from Spectrum Brands
- Strong sales, margin gains, and e-commerce growth drive improved profitability and outlook.SPB
Q3 20242 Feb 2026 - Sales and EBITDA rose in 2024, with 2025 guidance targeting further growth despite headwinds.SPB
Q4 202413 Jan 2026 - Net sales up 1.2%, net income up 40.6%, and 2025 growth outlook reaffirmed.SPB
Q1 202518 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay amid strategic transformation.SPB
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify KPMG, and approve executive pay, with strong ESG focus.SPB
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor ratification, and executive compensation.SPB
Proxy Filing1 Dec 2025 - Sales and EBITDA fell on tariffs and demand softness, but net income and EPS rose on cost cuts.SPB
Q3 202523 Nov 2025 - Q2 sales and profits dropped 6% as tariffs and weak demand drove supply chain shifts.SPB
Q2 202518 Nov 2025 - Sales and EBITDA fell, but free cash flow and net income improved; modest growth expected.SPB
Q4 202513 Nov 2025